NTC
PACB icon

North Tide Capital’s Pacific Biosciences PACB Stock Holding History

North Tide Capital’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$5.25M Buy
+1,000,000
New +$4.3M 1.12% 13

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

North Tide Capital's PACB Position: Q3 2017 in Review

North Tide Capital opened a new position in Pacific Biosciences (PACB) in Q3 2017: 1,000,000 shares worth $5.25M. The stake represents 1.12% of the portfolio and ranks #13 among its holdings.

98 funds tracked by Wall St. Rank hold PACB as of Q3 2017.

  • North Tide Capital held 1,000,000 shares of Pacific Biosciences worth $5.25M as of Q3 2017.
  • Pacific Biosciences was a new North Tide Capital position in Q3 2017.
  • Pacific Biosciences made up 1.12% of North Tide Capital's portfolio in Q3 2017, its #13 holding.
  • 98 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2017.

Based on North Tide Capital's 13F filing for Q3 2017, filed 14 Nov 2017.